Noradrenaline: friend or foe?

American College of Chest Physicians/ Society of Critical Care Medicine Consensus Committee, 1992, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Chest, 101, 1658 Schreuder, 1989, Effect of dopamine vs. norepinephrine on hemodynamics in septic shock, Chest, 95, 1282, 10.1378/chest.95.6.1282 Martin, 1993, Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?, Chest, 103, 1826, 10.1378/chest.103.6.1826 Desjars, 1987, A reappraisal of norepinephrine therapy in human septic shock, Crit. Care Med., 15, 134, 10.1097/00003246-198702000-00011 Moran, 1993, Epinephrine as an inotropic agent in septic shock: a dose profile analysis, Crit. Care Med., 21, 70, 10.1097/00003246-199301000-00015 Pawlik, 1975, Effect of vasoactive agents on intestinal oxygen consumption and blood flow in dogs, J. Clin. Invest., 56, 484, 10.1172/JCI108115 Shepherd, 1976, Effects of vasoconstrictors on intestinal vascular resistance and oxygen extraction, Am. J. Physiol., 230, 298, 10.1152/ajplegacy.1976.230.2.298 Gombos, 1962, Reactivity of renal and systemic circulations to vasoconstrictor agents in normotensive and hypertensive subjects, J. Clin. Invest., 41, 203, 10.1172/JCI104472 Mills, 1960, Effects of various sympathomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs, Am. J. Physiol., 198, 1279, 10.1152/ajplegacy.1960.198.6.1279 Richer, 1996, Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man, Crit. Care Med., 24, 1150, 10.1097/00003246-199607000-00014 Deitch, 1987, The gut as the portal of entry for bacteremia, Ann. Surg., 205, 681, 10.1097/00000658-198706000-00010 Schott, 1993, Dependence of endotoxin — induced vascular hyporeactivity on extracellular 1-arginine, Br. J. Pharmacol., 108, 38, 10.1111/j.1476-5381.1993.tb13436.x Kilbourn, 1990, N-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide, 87, 3629 Vallet, 1994, Gut and muscle tissue P02 in endotoxemic dogs during shock and resuscitation, J. Appl. Physiol., 76, 793, 10.1152/jappl.1994.76.2.793 Cronin, 1978, Pathogenic mechanisms in early norepinepherine-induced acute renal failure: functional and histological correlates of protection, Kidney Int., 14, 115, 10.1038/ki.1978.99 Cronin, 1978, Norepinephrine-induced acute renal failure: a reversible ischemic model of acute renal failure, Kidney Int., 14, 187, 10.1038/ki.1978.106 Schaer, 1985, Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy, Crit. Care Med., 13, 492, 10.1097/00003246-198506000-00011 Anderson, 1981, Mechanisms involved in the renal responses to intravenous and renal artery infusions of noradrenaline in conscious dogs, J. Physiol., 321, 21, 10.1113/jphysiol.1981.sp013969 Korner, 1967, Central nervous beta-adrenoreceptors and their role in the cardiovascular action of propranolol in rabbits, Circulation Res., 20, 676, 10.1161/01.RES.20.6.676 Zhang, 1997, Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxic shock, Am. J. Resp. Crit. Care Med., 155, 1965, 10.1164/ajrccm.155.6.9196103 Bersten, 1995, Renovascular interaction of epinephrine, dopamine, and intraperitoneal sepsis, Crit. Care Med., 23, 537, 10.1097/00003246-199503000-00020 Bersten, 1994, Epinephrine infusion in the sheep: systemic and renal hemodynamic effects, Crit. Care Med., 22, 994, 10.1097/00003246-199406000-00019 Bellomo, 1999, Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs, Am. J. Respir. Crit. Care Med., 159, 1186, 10.1164/ajrccm.159.4.9802055 Hesselvik, 1989, Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport, Crit. Care Med., 17, 179, 10.1097/00003246-198902000-00016 Meadows, 1988, Reversal of intractable septic shock with norepinephrine therapy, Crit. Care Med., 16, 663, 10.1097/00003246-198807000-00003 Martin, 1990, Renal effects of norepinephrine used to treat septic shock patients, Crit. Care Med., 18, 282, 10.1097/00003246-199003000-00007 Desjars, 1990, Norepinephrine therapy has no deleterious renal effects in human septic shock, Crit. Care Med., 18, 1048, 10.1097/00003246-199009000-00031 Rudis, 1996, Is it time to reposition vasopressors and inotropes in sepsis?, Crit. Care Med., 24, 525, 10.1097/00003246-199603000-00026 Redl-wenzel, 1993, The effects of norepinephrine on hemodynamics and renal function in severe shock states, Intensive Care Med., 19, 151, 10.1007/BF01720530 Bellomo, 1998, The use of inotropic and vasopressor agents in patients at risk of renal dysfunction, 1133 Martin, 2000, Effect of norepinephrine on the outcome of septic shock, Crit. Care Med., 28, 2758, 10.1097/00003246-200008000-00012